BACKGROUND: Recent reports have established the notion that many patients with longstanding type 1 diabetes (T1D) possess a remnant population of insulin-producing beta cells. It remains questionable, however, whether these surviving cells can physiologically sense and respond to glucose stimuli. METHODS: Frozen pancreatic sections from non-diabetic donors (n=8), type 2 diabetic patients (n=4), islet autoantibody-positive non-diabetic patients (n=3), type 1 diabetic patients (n=10) and one case of gestational diabetes were obtained via the network for Pancreatic Organ Donors. All longstanding T1D samples were selected based on the detection of insulin-producing beta cells in the pancreas by immunohistochemistry. RNA was isolated from all sections followed by cDNA preparation and quantitative real-time polymerase chain reaction for insulin, glucose transporter 1 (GLUT1), GLUT2 and GLUT3. Finally, immunofluorescent staining was performed on consecutive sections for all four of these markers and a comparison was made between the expression of GLUT2 in humans versus NOD mice. RESULTS: In contrast to islets from the most widely used T1D model, the NOD mouse, human islets predominantly express GLUT1 and, to a much lesser extent, GLUT3 on their surface instead of GLUT2. Relative expression levels of these receptors do not significantly change in the context of the various (pre-)diabetic conditions studied. Moreover, in both species preservation of GLUT expression was observed even under conditions of substantial leucocyte infiltration or decades of T1D duration. CONCLUSIONS: These data suggest that despite being subjected to multiple years of physiological stress, the remaining beta-cell population in longstanding T1D patients retains a capacity to sense glucose via its GLUTs.
BACKGROUND: Recent reports have established the notion that many patients with longstanding type 1 diabetes (T1D) possess a remnant population of insulin-producing beta cells. It remains questionable, however, whether these surviving cells can physiologically sense and respond to glucose stimuli. METHODS: Frozen pancreatic sections from non-diabetic donors (n=8), type 2 diabeticpatients (n=4), islet autoantibody-positive non-diabeticpatients (n=3), type 1 diabeticpatients (n=10) and one case of gestational diabetes were obtained via the network for Pancreatic Organ Donors. All longstanding T1D samples were selected based on the detection of insulin-producing beta cells in the pancreas by immunohistochemistry. RNA was isolated from all sections followed by cDNA preparation and quantitative real-time polymerase chain reaction for insulin, glucose transporter 1 (GLUT1), GLUT2 and GLUT3. Finally, immunofluorescent staining was performed on consecutive sections for all four of these markers and a comparison was made between the expression of GLUT2 in humans versus NODmice. RESULTS: In contrast to islets from the most widely used T1D model, the NODmouse, human islets predominantly express GLUT1 and, to a much lesser extent, GLUT3 on their surface instead of GLUT2. Relative expression levels of these receptors do not significantly change in the context of the various (pre-)diabetic conditions studied. Moreover, in both species preservation of GLUT expression was observed even under conditions of substantial leucocyte infiltration or decades of T1D duration. CONCLUSIONS: These data suggest that despite being subjected to multiple years of physiological stress, the remaining beta-cell population in longstanding T1D patients retains a capacity to sense glucose via its GLUTs.
Authors: Peter In't Veld; Dirk Lievens; Joeri De Grijse; Zhidong Ling; Bart Van der Auwera; Miriam Pipeleers-Marichal; Frans Gorus; Daniel Pipeleers Journal: Diabetes Date: 2007-06-11 Impact factor: 9.461
Authors: Y Tanizawa; A C Riggs; K C Chiu; R C Janssen; D S Bell; R P Go; J M Roseman; R T Acton; M A Permutt Journal: Diabetologia Date: 1994-04 Impact factor: 10.122
Authors: E H Liu; B J Digon; B Hirshberg; R Chang; B J Wood; Z Neeman; A Kam; R A Wesley; S M Polly; R M Hofmann; K I Rother; D M Harlan Journal: Diabetologia Date: 2009-05-06 Impact factor: 10.122
Authors: Inês Barroso; Jian'an Luan; Rita P S Middelberg; Anne-Helen Harding; Paul W Franks; Rupert W Jakes; D Clayton; Alan J Schafer; Stephen O'Rahilly; Nicholas J Wareham Journal: PLoS Biol Date: 2003-10-13 Impact factor: 8.029
Authors: Cristina M Fernández-Díaz; Beatriz Merino; José F López-Acosta; Pilar Cidad; Miguel A de la Fuente; Carmen D Lobatón; Alfredo Moreno; Malcolm A Leissring; Germán Perdomo; Irene Cózar-Castellano Journal: Am J Physiol Endocrinol Metab Date: 2019-09-03 Impact factor: 4.310
Authors: Alberto Pugliese; Francesco Vendrame; Helena Reijonen; Mark A Atkinson; Martha Campbell-Thompson; George W Burke Journal: Curr Diab Rep Date: 2014-10 Impact factor: 4.810
Authors: Alberto Pugliese; Mingder Yang; Irina Kusmarteva; Tiffany Heiple; Francesco Vendrame; Clive Wasserfall; Patrick Rowe; Jayne M Moraski; Suzanne Ball; Les Jebson; Desmond A Schatz; Roberto Gianani; George W Burke; Concepcion Nierras; Teo Staeva; John S Kaddis; Martha Campbell-Thompson; Mark A Atkinson Journal: Pediatr Diabetes Date: 2013-12-10 Impact factor: 4.866